Sonia Martı́nez

Spanish National Cancer Research Centre — Spain

Medicine · Health Sciences

24h-index2.3kcitations83works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Mechanisms and Therapy(11), PI3K/AKT/mTOR signaling in cancer(10), Chronic Lymphocytic Leukemia Research(7), Synthesis and biological activity(6), Quinazolinone synthesis and applications(6)

Publications82 total

Identification of epigenetic regulators of fibrotic transformation in cardiac fibroblasts through bulk and single-cell CRISPR screens
Nature Communications·2025Open Access
Identification of Epigenetic Regulators of Fibrotic Transformation in Cardiac Fibroblasts Through Bulk and Single-Cell CRISPR Screens
2025Open Access
Estrategias financieras y aspectos fiscales del sector empresarial en Colombia
Ediciones Universidad Simón Bolívar eBooks·2025Open Access
Dual Targeting of Pim and <scp>PI3</scp> Kinases in Mature T‐Cell Lymphoma
European Journal Of Haematology·2025Open Access
Identification of epigenetic regulators of fibrotic transformation in cardiac fibroblasts through bulk and single-cell CRISPR screens
2025· 1 citedOpen Access
359 Preclinical models for T-Plex, a customized multiplexed TCR-T cell therapy addressing intra-tumor antigen and HLA heterogeneity
Regular and Young Investigator Award Abstracts·2024Open Access
SETD8 inhibition targets cancer cells with increased rates of ribosome biogenesis
Cell Death and Disease·2024· 2 citedOpen Access
SETD8 inhibition targets cancer cells with increased rates of ribosome biogenesis
2024Open Access
Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits
Cancer Cell·2023· 31 citedOpen Access
BSBM-21 MACHINE LEARNING IDENTIFIES EXPERIMENTAL BRAIN METASTASIS SUBTYPES BASED ON THEIR INFLUENCE ON NEURAL CIRCUITS
Neuro-Oncology Advances·2023Open Access
A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
EMBO Molecular Medicine·2022· 33 citedOpen Access
Macrocyclization as a Source of Desired Polypharmacology. Discovery of Triple PI3K/mTOR/PIM Inhibitors
ACS Medicinal Chemistry Letters·2021· 12 citedOpen Access
Corrigendum to &lt;’ Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors’ [Eur. J. Med. Chem. 211 (2021), 113109]
European Journal of Medicinal Chemistry·2021
Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors
European Journal of Medicinal Chemistry·2020· 21 citedOpen Access
A drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent local relapse and treat established brain metastasis
2020· 3 cited
Global hyperactivation of enhancers stabilizes human and mouse naive pluripotency through inhibition of CDK8/19 Mediator kinases
Nature Cell Biology·2020· 63 citedOpen Access
42. IDENTIFICATION OF BRAIN METASTASIS VULNERABILITIES USING METPLATFORM
Neuro-Oncology Advances·2020Open Access
Induction of Lysosome Membrane Permeabilization as a Therapeutic Strategy to Target Pancreatic Cancer Stem Cells
Cancers·2020· 12 citedOpen Access
Pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one derivatives as CDK8 inhibitors
European Journal of Medicinal Chemistry·2020· 13 citedOpen Access
Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer
Oncogene·2020· 34 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Joaquı́n Pastor(32), Carmen Blanco‐Aparicio(17), María I. Albarrán(11), James R. Bischoff(9), David Cebrián(9), Rosa M. Álvarez(9), Carmen Varela(8), Antonio Cebriá(8), Julen Oyarzábal(7), Ana Isabel Hernández(7), Manuel Serrano(5), Elena Gómez‐Casero(5), Sonsoles Rodríguez-Arístegui(5), Ana Belén Garcı́a(5), Milagros Lorenzo(5), Maribel Muñoz‐Martín(4), Francisca Mulero(4), José Ignacio Andrés(4), Jesús Alcázar(4), Michael F. O‘Neill(4)